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Is consuming yoghurt associated with weight management
outcomes? Results from a systematic review
J Eales1, I Lenoir-Wijnkoop2, S King1, H Wood1, FJ Kok3, R Shamir4, A Prentice5, M Edwards1, J Glanville1 and RL Atkinson6
BACKGROUND: Yoghurt is part of the diet of many people worldwide and is commonly recognised as a ‘health food’.
Epidemiological studies suggest that yoghurt may be useful as part of weight management programs. In the absence of
comprehensive systematic reviews, this systematic review investigated the effect of yoghurt consumption by apparently healthy
adults on weight-related outcomes.
METHODS: An extensive literature search was undertaken, as part of a wider scoping review, to identify yoghurt studies. A total of
13 631 records were assessed for their relevance to weight-related outcomes.
RESULTS: Twenty-two publications were eligible according to the review protocol. Cohort studies (n= 6) and cross-sectional studies
(n= 7) all showed a correlation between yoghurt and lower or improved body weight/composition. Six randomised controlled trials
(RCTs) and one controlled trial had various limitations, including small size and short duration. One RCT showed signiﬁcant effects
of yoghurt on weight loss, but was confounded by differences in calcium intake. One trial showed nonsigniﬁcant weight gain and
the remaining ﬁve trials showed nonsigniﬁcant weight losses that were greater in yoghurt consumers.
CONCLUSIONS: Yoghurt consumption is associated with lower body mass index, lower body weight/weight gain, smaller waist
circumference and lower body fat in epidemiological studies. RCTs suggest weight reduction effects, but do not permit
determination of a cause–effect relationship. Well-controlled, adequately powered trials in research and community settings appear
likely to identify a modest but beneﬁcial effect of yoghurt consumption for prevention of weight gain and management of obesity.
The ready availability of yoghurt (a nutrient-dense food) and its ease of introduction to most diets suggests that educating the
public to eat yoghurt as part of a balanced and healthy diet may potentially contribute to improved public health. Future carefully
designed RCTs could provide proof of principle and large community-based studies could determine the practical impact of
yoghurt on body weight/composition.
International Journal of Obesity (2016) 40, 731–746; doi:10.1038/ijo.2015.202
INTRODUCTION
Conventional (non-probiotic) yoghurt is a common feature of the
food consumption patterns of people worldwide. The beneﬁcial
health effects of yoghurt have been the subject of investigation
for over a century using observational and experimental studies.1,2
The Codex Alimentarius International Food Standards deﬁne
yoghurt as a form of fermented milk that contains symbiotic
cultures of Streptococcus thermophilus (sp) subsp. salivarius and
Lactobacillus delbrueckii subsp. bulgaricus.3 Conventional yoghurt
must contain milk protein (minimum 2.7%), milk fat (o15%),
lactic acid (minimum 0.6%) and microorganisms in the proper
proportions.3 It does not have the additional further strains of
probiotic bacteria,4 such as Biﬁdobacterium lactis or Lactobacillus
acidophilus, which feature in probiotic yoghurt. Probiotic yoghurt
has been the subject of much primary research and systematic
reviews over the past two decades, but the evidence picture for
conventional yoghurt has not been extensively investigated.
The efﬁcacy of yoghurt has been investigated in a wide range of
separate and overlapping outcomes including weight-related
outcomes,5 type 2 diabetes,6 cardiovascular disease risk,7 the risk
of cancer,8 gastrointestinal health,9 diarrhoea symptoms,10
malnutrition11 and overall mortality.12 Systematic reviews (some
involving meta-analysis) have been conducted in relation to only a
few of these outcomes. Their limited results suggest that
consuming yoghurt may reduce the risk of developing type 2
diabetes,13–15 but may have no effect on the risk of developing
colorectal cancer,16 hypertension17 or overall mortality.18 A
systematic review of the effects of conventional yoghurt
consumption on weight-related outcomes has not been pub-
lished, to our knowledge. In an increasingly obese population, it
would be of value for public health strategies to know whether an
inexpensive and commonly consumed foodstuff can assist in
weight-related outcomes. This review was conducted to investi-
gate the effectiveness of standard yoghurt on a range of weight-
related outcomes in the general, apparently healthy, adult
population. The review was also designed to identify data on
effectiveness in prespeciﬁed subgroups such as people at risk of
diabetes, and people from different ethnic groups.
METHODS
This review was conducted using systematic review methods,
involving the systematic and transparent identiﬁcation, selection,
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extraction and synthesis of studies relevant to the research
question.19 The review is reported in accordance with the
Preferred Reporting Items for Systematic Reviews and Meta-
Analyses (PRISMA) reporting guidance.20 The completed PRISMA
checklist is provided in the Supplementary File. Details of the
protocol for this systematic review were registered on PROSPERO
and can be accessed at www.crd.york.ac.uk/PROSPERO/display_
record.asp?ID=CRD42014013883.
Review question
This review aimed to investigate the effects of yoghurt containing
the symbiotic cultures Streptococcus thermophilus (sp) subsp.
salivarius and Lactobacillus delbrueckii subsp. bulgaricus on weight-
related outcomes in the general, apparently healthy, adult
population. The eligibility criteria, used to select the studies to
be included in the review, were developed from the review
question. They are summarised below and presented in detail in
the Supplementary File.
Participants
Eligible studies assessed apparently healthy adults (18–65 years)
or mixed populations where separate results were presented for
the 18–65 years age group.
Studies reporting data for subgroups of the general population
who were at high risk of weight change were eligible for inclusion,
for example, people with insulin resistance, diabetes or obesity
(body mass index (BMI), between 30 and 40 kgm− 2).
Studies in speciﬁc populations were excluded because
we were interested in the effects in a generally healthy, normal
population. Therefore, people with severe or morbid obesity
(BMI ⩾ 40.00 kgm− 2), people with a single speciﬁc disease or
symptom and people training for or undertaking physical activity
at a professional level were excluded.
Interventions
Eligible studies investigated consumption of yoghurt (all ﬂavours
and fat contents were eligible) containing the standard symbiotic
cultures. Studies of yoghurt in combination with another
substance (e.g. added protein/vitamins/fats) were not eligible as
yoghurt was likely being used as a carrier substance for an active
ingredient and hence was not the focus of the investigation.
Studies of probiotic yoghurt, fermented milk or formula, keﬁr or
kumys were not eligible for inclusion.
Comparators
Eligible studies had to compare yoghurt with at least one of the
following:
1. low or no yoghurt consumption;
2. placebo (e.g. yoghurt-like products not including live bacteria);
3. non-yoghurt substances (e.g. milk);
4. non-yoghurt interventions (e.g. nutritional counselling).
Outcomes
Eligible studies had to assess the interventions in relation to at
least one weight-related outcome: body weight, BMI, percent
body fat, percent lean body mass, waist circumference (WC) or
composite measures of the above weight-related outcomes.
Study types
Randomised and quasi-randomised controlled trials (RCTs), con-
trolled clinical trials, comparative observational studies (including
cross-sectional studies, cohort studies and case–control studies)
and systematic reviews were eligible for the review. Studies
published as abstracts, conference presentations or unpublished
reports were eligible.
Literature search
An extensive literature search was undertaken, as part of a wider
scoping review to identify yoghurt studies published in the health
sciences. Search terms were based on synonyms for the
intervention (yoghurt) and the full searches for all resources are
listed in the Supplementary File. The searches were not limited by
date or language. Searches were undertaken in 39 databases and
websites in October 2014. The reference lists of relevant reviews,
trials and studies were checked to identify any further studies.
Study selection
Records identiﬁed by the searches were ﬁrst assessed for
relevance by one reviewer (ME) to rapidly remove obviously
irrelevant records. Record selection was then undertaken by two
reviewers independently, based on information in the title and
abstract of records. Where possible, the full documents of possibly
relevant studies were obtained and were assessed for relevance
by one reviewer (JE) and checked by a second independent
reviewer (SK). In the latter two stages, discrepancies were resolved
through discussion and, where necessary, by consulting a third
reviewer (JG). Studies that were considered ineligible at this stage
were recorded in a table with reasons for exclusion (see
Supplementary File). Studies that were unobtainable are included
in the Supplementary File. The number of studies identiﬁed by the
search and excluded at various stages are shown in a record
selection diagram (Figure 1).20
Data extraction and quality assessment
One researcher (JE) extracted the data and study information from
the eligible studies into Excel, and a second researcher (DC or SK)
checked the extraction. Any discrepancies were resolved through
discussion or by consulting a third reviewer (JG). Data were
extracted from abstracts when no full document was available.
Data extraction elements are listed in the Supplementary File.
When required information was not presented in a document, it
was requested from the study authors.
Quality assessment of the internal and external validity of
eligible studies was undertaken using the Cochrane Risk of Bias
tool for RCTs, controlled trials and cross-over trials,19 the Centre for
Reviews and Dissemination tool for cohort studies21 and the
Newcastle-Ottawa Quality Assessment Scale adapted for cross-
sectional studies (see Supplementary File for details).22 Quality
assessment was conducted by one researcher (JE) and checked by
a second researcher (DC or SK). Any disagreements were discussed
between the reviewers.
Data synthesis
Following an assessment of the comparability of their populations,
interventions and outcomes, only a few RCTs provided data
suitable for meta-analysis for some outcomes. Lack of raw data
reporting was another factor preventing the meta-analysis of
cohort and cross-sectional studies. Meta-analysis was conducted
using a random-effects model as the RCTs were somewhat
heterogeneous (e.g. different ethnic composition of study groups).
Because the number of studies was small, the analyses were also
conducted using a ﬁxed-effect model.
Heterogeneity was assessed using the χ2 and I2 statistics, where
an I2 of 0–25% represents no heterogeneity, 25–50% represents
moderate heterogeneity, 50–75% represents substantial hetero-
geneity and 75–100% represents considerable heterogeneity. The
level of statistical signiﬁcance for effect size and summary effect
size was set at Po0.05.
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Raw data provided by study authors was used for the mean and
s.d. of weight-related outcomes. These data were pooled to
estimate the combined effect size (mean difference with 95%
conﬁdence intervals (CIs)) across studies for:
● Change in body weight in participants with an energy-
restricted diet.
J Yoghurt vs control (three RCTs).
● Change in waist circumference (WC) in participants with an
energy-restricted diet.
J Yoghurt vs control (two RCTs).
● Change in body fat in participants with an energy-
restricted diet.
J Yoghurt vs control (two RCTs).
Where standard error of the mean was reported, rather than
standard deviation, the standard deviation was calculated using
the formula:
SD ¼ SEM  ﬃpN
where s.e.m. is the standard error of the mean and N the
sample size.
The results from the meta-analyses are graphically presented
as forest plots. All analyses were conducted using RevMan
version 5.3. Where possible, a sensitivity analysis was undertaken,
excluding studies with a high risk of bias.
RESULTS
Search results
A total of 13 631 records (after deduplication) were identiﬁed by
extensive searches (see Supplementary File for details). Of these,
69 full documents were assessed for relevance to the topic of
yoghurt for weight-related outcomes (Figure 1). Two reports
published as abstracts were potentially relevant, but were
excluded as further details were not provided by the
authors.23,24 Twenty-two studies (reported in 28 documents) were
included in the review (Table 1).25–45
Characteristics of included studies
Study characteristics are provided in Table 1. There were six
RCTs, one controlled trial (CT), two cross-over studies, one
prospective cohort study, ﬁve retrospective population-based
cohort studies and seven cross-sectional studies. The studies
were carried out in the USA (n = 14), Korea (n= 1),
Malaysia (n = 1), Spain (n= 1), Australia (n= 1), Canada (n= 2),
France (n = 1) and one study did not report the location.
Where reported, study dates ranged from 197932 to September
2010.34
Generally, RCTs, cross-over trials and the prospective cohort
study had the smallest study sizes. RCTs generally had the shortest
duration (range: 14 days25 to 24 weeks26).
Cross-sectional and population-based cohort study numbers
ranged from 72 participants45 to 14 500 participants,41 with an
outlying large study of 120 877 participants.36 Cohort study
duration ranged from 5.9 years35 to 12.9 years.39
Records identified through 
database searching  
(n = 18051) 
Records after duplicates removed  
(n = 13631) 
Records screened  
(Title and abstract)
(n = 13631)  
Full-text documents  
assessed for eligibility  
(n = 69)  
Studies included in the
review (n=22) 
Documents included in
review (n = 28) 
Additional (sp) records identified through 
other sources  
(n = 31) 
Records excluded by 
assessing title and 
abstract  
(n = 13562) 
Full-text documents 
excluded 
(n = 41) 
Figure 1. Record selection process. Above the dashed line indicates records retrieved from a wide scoping search for studies of yoghurt in the
health science literature. Below the dashed line indicates where study selection criteria for this systematic review (yoghurt for weight-related
outcomes were applied.
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Table 2. Summary of included studies
Study reference; study type and participants Summary of relevant outcome results
BMI
Albertson et al.40
Retrospective cross-sectional study; 8552 analysed
Yoghurt eaters had lower BMI compared with non-yoghurt eaters (Po0.01).
After adjusting for all covariates, yoghurt consumption was associated with a
lower BMI for both males (Po0.001) and females (Po0.001)
Beydoun et al.41
Retrospective cross-sectional study; 14 618 participants
Yoghurt consumption was associated with reduced BMI for both genders,
when analysed together and separately (Po0.05)
Gugger et al.42
Retrospective cross-sectional study; 2883 (dropouts not reported)
Women who consumed at least one serving of yoghurt had a signiﬁcantly
lower BMI compared with those consuming no yoghurt (P= 0.001)
Joshi et al.43
Retrospective cross-sectional study; 2672 (no dropouts reported)
After adjusting for covariates, yoghurt eaters’ BMI was lower compared with
non-yoghurt eaters by 1.3 kgm− 2 (P= 0.03) and waist-to-height ratio was
lower by 2% (P= 0.02)
Murphy et al.45
Prospective cross-sectional study; 720 participants
Yoghurt consumption was not associated with BMI in any models
Shilsky et al.26
RCT; 76 randomised
Both yoghurt and control groups: signiﬁcant decreases in BMI over 24 weeks
(Po0.05), NS between groups (P-value NR)
Thomas et al.27
RCT; 35 recruited (29 after dropouts)
Both yoghurt and control groups: signiﬁcant decrease in BMI (P= 0.003),
NS between groups (P= 0.584)
Wang et al.46
Retrospective cross-sectional study; 6526 participants
Yoghurt consumers had signiﬁcantly lower BMI compared with
non-consumers (Po0.001)
Body weight
Al-Naggar et al.25
RCT; 30 recruited (30 completed)
Unclear
Bazzarre et al.32
Cross-over trial; 30 recruited (20 analysed)
NS change for males (P= 0.30) or female (P= 0.059) across the study period
Drapeau et al.35
Retrospective population-based cohort study; 248 participants
In all models: changes in yoghurt consumption were NS related to body
weight change
Jordan et al.31
Controlled trial; 528 randomised (268 completed)
High yoghurt eaters moved closer to an ideal (lower) weight compared to
low yoghurt eaters, but regression analysis indicated no signiﬁcant
relationship between the frequency of yoghurt ingestion and weight loss
McNamara et al.33
Cross-over trial; 18 participants (no dropouts reported)
No signiﬁcant weight changes (P-values NR)
Mozaffarian et al.36
Retrospective population-based cohort study; 120 877
participants
Increased consumption of yoghurt was correlated with decreased weight
gain across the 4-year periods, when controlling for age and also when
baseline BMI and all lifestyle factors were added as covariates
Shilsky et al.26
RCT; 76 randomised
Both groups: signiﬁcant decreases in body weight over 24 weeks (Po0.05),
NS between groups (P-value NR)
Thomas et al.27
RCT; 35 recruited (29 after dropouts)
Both groups: signiﬁcant decrease in body weight (P= 0.007), NS between
groups (P= 0.391)
Thompson et al.28
RCT; 56 recruited
Over 3 weeks, a small, signiﬁcant increase in body weight for yoghurt
(Po0.001)
Vergnaud et al.38
Retrospective, population-based cohort study; 2267 participants
Yoghurt consumption was associated with smaller increases in body weight
over 6 years in overweight men. An opposite (positive) trend was seen in
normal-weight women
Wang et al.39
Retrospective population-based cohort study; 3440 participants
High yoghurt consumers had 450% smaller weight gain over 12.9 years
compared with low consumers (P= 0.03), in a model adjusted for covariates
White et al.29
RCT; 45 recruited (42 completed; 35 compliant)
Nonsigniﬁcant trend for increase in weight during the study in yoghurt and
CHO+PRO groups, but not CHO only
Zemel et al.30
RCT; 38 recruited (34 completed)
Yoghurt group lost 22% more weight compared with control (Po0.01)
WC
Albertson et al.40
Retrospective cross-sectional study; 8552 analysed
Yoghurt eaters had signiﬁcantly lower WC compared with non-yoghurt
eaters (Po0.01). After adjusting for all covariates, yoghurt consumption was
associated with a lower WC for both males (Po0.001) and females (Po0.001)
Al-Naggar et al.25
RCT; 30 recruited (30 completed)
Unclear
Beydoun et al.41
Retrospective cross-sectional study; 14 484 participants
Yoghurt was associated with reduced WC for both genders, when analysed
together and separately (Po0.05)
Drapeau et al.35
Retrospective population-based cohort study; 248 participants
Signiﬁcant positive effect of changes in yoghurt consumption on WC in all
models, including the full model with adjustments for covariates (P= 0.003)
Joshi et al.43
Retrospective cross-sectional study; 2672 (no dropouts reported)
After adjusting for covariates, WC of yoghurt eaters was lower compared with
non-yoghurt eaters by 3.5 cm (P= 0.02)
Murphy et al.45
Prospective cross-sectional study; 720 participants
Yoghurt consumption was inversely associated WC in the basic model
(Po0.01), and remained so with adjustment for other dairy intake (Po0.05)
Shilsky et al.26
RCT; 76 randomised
Both groups: signiﬁcant decreases in WC over 24 weeks (Po0.001),
NS between groups (P-value NR)
Thomas et al.27
RCT; 35 recruited (29 after dropouts)
Both groups: signiﬁcant decrease in WC (P= 0.0001), NS between groups
(0.914)
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Baseline anthropometrics
Seven studies included normal-weight or borderline overweight
participants.28,33–36,38,44 Nine studies were in overweight25,27,37 or
obese participants,39,41 or overweight/obese participants.26 Six
studies did not clearly report baseline anthropometric data.
Percentage males
Where reported (19 studies), the sex ratio varied largely between
studies. Five studies recruited females only.26,27,29,42,43 One cross-
over trial recruited males only.33 In Mozaffarian et al.,36 the NHSI
and NHSII cohorts were all female and the HPFS cohort was all
male, all pooled for analysis.36 In 12 studies of mixed populations,
the percentage of male participants ranged from ~16%31 to 55%.38
Interventions and comparators
The detailed study methods for all studies are presented in the
Supplementary File. The intervention was generally described as
‘yoghurt’, although some RCTs and cross-over trials speciﬁed the
yoghurt brand (e.g. Yoplait, Kraft, Dannon). Population-based
cohort studies and cross-sectional studies often used food
Table 2. (Continued )
Study reference; study type and participants Summary of relevant outcome results
Vergnaud et al.38
Retrospective, population-based cohort study; 2267 participants
Yoghurt was associated with lower increases in WC in overweight men only,
over 6 years
Wang et al.46
Retrospective cross-sectional study; 6526 participants
Yoghurt consumers had signiﬁcantly smaller WC compared with non-
consumers (Po0.001)
Wang et al.39
Retrospective population-based cohort study; 3440 participants
High consumers of yoghurt gained about 20% less WC per year compared
with low yoghurt consumers (P= 0.03), in a model adjusted for covariates
Zemel et al.30
RCT; 38 recruited (34 completed)
WC decreased in the yoghurt group compared with the control group
(Po0.001)
Body fat
Drapeau et al.35
Retrospective population-based cohort study; 248 participants
No association between low-fat yoghurt and two adiposity measures: change
in percentage body fat or change in the sum of 6 skinfold thicknesses over
5.9 years
Joshi et al.43
Retrospective cross-sectional study; 2672 (no dropouts reported)
After adjusting for covariates, % body fat was lower than non-yoghurt eaters
by 1.5% (P= 0.03)
Murphy et al.45
Prospective cross-sectional study; 720 participants
Yoghurt consumption was signiﬁcantly inversely associated with % body fat
in all models. Yoghurt consumption was inversely correlated with abdominal
fat (Po0.05) in the basic model, and after full adjustment for dairy intake to
the model (Po0.05)
Shilsky et al.26
RCT; 76 randomised
Both groups: signiﬁcant decreases in fat mass over 24 weeks (Po0.05), NS
between group (P-value NR)
Thomas et al.27
RCT; 35 recruited (29 after dropouts)
Both groups: signiﬁcant decrease in % body fat (P= 0.0001), NS between
groups (0.610)
White et al.29
RCT; 45 recruited (42 completed; 35 compliant)
All groups: signiﬁcant decrease in % body fat (P= 0.02). NS difference
between groups
Zemel et al.30
RCT; 38 recruited (34 completed)
Yoghurt group lost 61% more fat (Po0.005) and 81% more trunk fat
(Po0.01) compared with control
Lean body mass
Thomas et al.27
RCT; 35 recruited (29 after dropouts)
Both groups: signiﬁcant increase in % lean body mass (P= 0.0001), NS
between groups (P= 0.551)
White et al.29
RCT; 45 recruited (42 completed; 35 compliant)
All groups: signiﬁcant increase in fat-free mass (P= 0.02). NS between groups
(P= 0.5)
Zemel et al.30
RCT; 38 recruited (34 completed)
Signiﬁcantly more lean body mass was lost on control diet compared with
the yoghurt diet (Po0.05)
Risk/proportion of overweight/obesity
Albertson et al.40
Retrospective cross-sectional study; 8552 analysed
A lower proportion of overweight female yoghurt eaters compared with non-
yoghurt eaters (Po0.001). After adjusting for all covariates, yoghurt
consumption was associated with a lower percent overweight for females
(Po0.001) and directionally lower percent overweight for males (NS)
Beydoun et al.41
Retrospective cross-sectional study; 14 618 participants
Yoghurt was negatively associated with obesity, BMI ⩾ 30 (Po0.05) and
central obesity (Po0.05). No signiﬁcant effects found in the subgroup of
non-Hispanic blacks
Gugger et al.42
Retrospective cross-sectional study; 2883 (dropouts not reported)
More frequent yoghurt consumption was associated with a signiﬁcantly
lower incidence of overweight/obesity (Po0.05)
Lee et al.44
Retrospective cross-sectional study; 7173 (no dropouts reported)
Higher intake of yoghurt (measured in a Food Frequency Questionnaire) was
associated with a lower prevalence of obesity (P= 0.01), in a model adjusted
for covariates. Yoghurt consumption (measured from 24-h recall data) was
not associated with obesity (P= 0.23) in a model adjusted for covariates
Martinez-Gonzalez et al.34
Prospective cohort study; 9506 recruited (8516 completed with
no missing values)
High yoghurt consumption was associated with a lower risk of overweight/
obesity when compared with low consumption (P-value for trend o0.001).
The signiﬁcance was for all yoghurt and whole fat yoghurt but not low fat
Pereira et al.37
Retrospective population-based cohort study; 923 participants
Odds of overweight participants developing obesity reduced (NS) with
increased consumption of yoghurt, controlling for confounders
Abbreviations: BMI, body mass index; NR, not reported; NS, nonsigniﬁcant; RCT, randomised controlled trial; WC, waist circumference.
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frequency questionnaires, recall data or dietary records to
ascertain yoghurt consumption. Across the different food
frequency questionnaires, the interpretation of ‘yoghurt’ is likely
to be different, and it is possible that probiotic yoghurts may have
been included. Deﬁnitions of yoghurt consumption levels varied
across studies: high consumption was at least seven times a week
in Martinez-Gonzalez et al.,34 but only three servings a week in
Gugger et al.34,42 In the RCTs, doses of yoghurt varied between at
least four times per week31 and 1 L of yoghurt daily.28 The cross-
over trials reported similar doses of yoghurt during the interven-
tion period: 16 oz (454 g), daily;33 8 oz (227 g), three times a day.32
Within the study types, comparators varied widely and included
other dairy products, dietary supplements, placebo food products
or no intervention (i.e. low or no yoghurt, or non-consumers).
Unless otherwise speciﬁed, the comparator dose was the same as
or similar to the intervention dose within a study. Where a variety
of foods were potential comparators (e.g. food frequency
questionnaires), we deﬁned a suitable comparator as that which
was most similar to yoghurt: milk and/or milk drinks.
Four of the six RCTs and the controlled trial reported that an
energy-restricted diet and/or physical activity change was
adopted by both the treatment and control groups for the
duration of the trial. One cross-over trial, McNamara et al.,33
speciﬁed that participants stayed on a controlled low-fat, low-
cholesterol diet. Two RCTs investigated the effect of consuming
yoghurt around the time of exercise.27,29
Quality assessment
The detailed quality assessment is presented in the
Supplementary File. Two RCTs had a low risk of bias in the
summary assessment.27,30 The remaining ﬁve RCTs/CT had a high
risk of bias, due to non-completers, problems with randomisation
and conﬂicts of interest. Al-Naggar et al.25 was poorly reported,
such that the results were questionable and the authors’
responses to queries were unclear: the results of the paper were
therefore excluded from the systematic review.25 The summary
quality assessment for both cross-over trials was a high risk of bias
due to incomplete data32 and funders with conﬂict of interests.33
The prospective cohort study by Martinez-Gonzalez et al.34 had
a low risk of bias. All of the retrospective cohort studies had an
unclear risk of bias. They did not provide sufﬁcient information to
determine whether groups were comparable on confounding
variables. However, we note that the studies were not designed to
provide comparable groups and that four of the ﬁve adjusted for
confounding variables.35,37–39
The cross-sectional studies’ summary quality assessments
ranged from 6 to 8 stars out of a maximum of 10 on the adapted
Newcastle-Ottawa scale. Although none of the studies received a
star for ‘sample size justiﬁcation’ or ‘non-respondents’, this is likely
to be a reﬂection of the retrospective nature of the majority of
studies (6/7), where information on non-respondents may not be
available. Taking this into account, we report a generally low risk
of bias across the seven cross-sectional studies.
Yoghurt consumption and BMI
Four cross-sectional studies40–43 (generally low risk of bias)
showed that yoghurt consumers have a signiﬁcantly lower BMI
compared with non-consumers, but two RCTs26,27 (one low, one
high risk of bias) did not show a signiﬁcant difference in the
decrease in BMI between yoghurt and placebo groups over time
(Table 2). An association between high yoghurt consumption and
low BMI was reported by one cross-sectional study,39 but another
cross-sectional study45 did not show the trend.
One low risk of bias RCT27 reported signiﬁcant decreases in BMI
for overweight/obese women following a calorie-deﬁcit diet with
resistance training in both the yoghurt and control (isotonic
placebo beverage) groups over 16 weeks (P= 0.003). There was,
however, no signiﬁcant difference between the groups (P= 0.584).
One high risk of bias study26 also showed a signiﬁcant decrease in
BMI for overweight/obese women in both yoghurt and control
groups on an energy-restricted diet and exercise programme over
24 weeks (Po0.05), but there was no difference between groups.
Comparative evidence from four cross-sectional studies was
consistent in showing that yoghurt consumers had a signiﬁcantly
lower BMI compared with non-consumers in both sexes39,46 and
females only.42,43 Evidence from one cross-sectional study
supports the trend, reporting a negative correlation between
yoghurt consumption and BMI in both genders.41 Conversely, one
cross-sectional study did not show the same trend for yoghurt, but
did show it for reduced fat milk.45 The cross-sectional studies had
a generally low risk of bias and the majority of studies adjusted for
confounding factors such as age, baseline weight, diet and
lifestyle factors.
Yoghurt consumption and body weight
One RCT30 (low risk of bias) showed that yoghurt consumption
signiﬁcantly reduced body weight compared with a placebo, but
two other RCTs26,27 (one low, one high risk of bias) and two cross-
over trials32,33 (high risk of bias) did not ﬁnd a signiﬁcant
difference (Table 2). An association between high yoghurt
consumption and low body weight was reported by one
retrospective cohort study (Wang et al.,39 unclear risk of bias)
and one CT (Jordan et al.,31 high risk of bias); conversely, a small,
signiﬁcant increase in body weight with yoghurt consumption was
reported by one RCT28 (high risk of bias).
Evidence from a low risk of bias RCT30 indicated that when part
of an energy-restricted diet for overweight/obese people, yoghurt
supplementation can help to signiﬁcantly reduce body weight
compared with a placebo (sugar-free gelatin dessert) over
12 weeks. Conversely, two RCTs involving energy-restricted diets
(one at high risk of bias and one at low risk of bias) reported no
signiﬁcant differences between yoghurt and control groups (the
comparators were: standard protein diet with no added yoghurt
and an isotonic placebo beverage).26,27 The forest plot in Figure 2ai
indicates greater weight loss in participants consuming yoghurt
compared with the comparator group (−0.99, 95% CI: − 2.21, 0.23),
but the effect size was not signiﬁcant (P=0.11). In a sensitivity
analysis, excluding the study with a high risk of bias,26 the summary
effect size became larger (−1.58, 95% CI: −2.90, −0.26) and reached
statistical signiﬁcance (P=0.02) (Figure 2aii). In both standard
analysis and sensitivity analysis, heterogeneity was low for both
the ﬁxed-effect and random-effects models (14% and 0%, respec-
tively). The summary effect sizes were similar in the ﬁxed-effect
model (Z=−1.80, P=0.07 and Z=− 2.34, P=0.02, respectively).
The two cross-over trials did not ﬁnd any signiﬁcant change in
body weight between the yoghurt and control (calcium carbonate
pills; 2% non-fermented milk) phases of the trials. Both studies had
a high risk of bias, were conducted for short treatment periods
and participants were of normal weight, or weight was not
reported. Because the mean and s.d. of weight change was not
reported for the yoghurt and control groups by either of the
studies, meta-analysis was not possible.
High yoghurt consumers gained signiﬁcantly less weight
compared with low yoghurt consumers in one retrospective
cohort study (Wang et al.,39 unclear risk of bias) and a similar,
nonsigniﬁcant trend was reported in the controlled trial by Jordan
et al.31 A signiﬁcant association between increasing yoghurt
consumption and decreasing weight gain was found in another
retrospective cohort study,36 mixed results in another38 and a
nonsigniﬁcant effect in the remaining study.35 Two RCTs,28,29 both
with high risk of bias, reported an increase in body weight with
yoghurt consumption, with a similar body weight increase also
being reported in some, but not all comparator groups. These
trials are discussed below.
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Yoghurt consumption and WC
One RCT30 (low risk of bias) and three cross-sectional studies (low
risk of bias) indicated that consumers of yoghurt had signiﬁcantly
lower WC compared with control/non-consumers of yoghurt
(Table 2). Conversely, two RCTs26,27 (one low, one high risk of bias)
did not ﬁnd a signiﬁcant difference. A signiﬁcant association
between high yoghurt consumption and low WC was reported by
two cohort studies38,39 (for overweight men only, in one of these)
and two cross-sectional studies.45,46 One cohort study35 showed a
signiﬁcant positive effect.
One low risk of bias RCT30 showed a signiﬁcant decrease in the
WC of overweight/obese people consuming yoghurt compared
with a control group (sugar-free gelatin dessert) after 12 weeks on
an energy-restricted diet. In contrast, one low27 and one high risk
of bias26 RCT of overweight/obese people on energy-restricted
diets reported no difference between groups. Shilsky et al.26 and
Zemel et al.30 provided data that could be pooled (Figure 2b). The
summary effect size indicated a nonsigniﬁcant beneﬁt for yoghurt
over control in terms of WC: − 1.47 (95% CI: − 5.11, 2.16) (P= 0.43).
Because of the high risk of bias of Shilsky et al.,26 the summary
effect should be interpreted with caution. The summary effect size
was not signiﬁcant for the ﬁxed-effect model (Z=− 1.47; P= 0.14),
and heterogeneity was considerable (I2 = 85%) for both the ﬁxed-
effect and random-effects models, suggesting caution when
interpreting the summary effect size. This heterogeneity may be
because of a difference in participant numbers between studies,
different comparators or differences in participants at baseline
(sex, ethnicity).
Three low risk of bias cross-sectional studies reported that
yoghurt consumers had signiﬁcantly smaller WC compared with
non-consumers (both sexes together: Wang et al.;46 both sexes
separately: Albertson et al.;40 females only: Joshi et al.43).
Outcome: Change in body weight 
i. All three RCTs 
ii. Sensitivity analysis excluding RCT with a high risk of bias 
Outcome: Change in WC  
Outcome: Change in body fat  
Study or Subgroup
Shilsky
Thomas
Zemel
Total (95% CI)
Heterogeneity: Tau² = 0.18; Chi² = 2.33, df = 2 (P = 0.31); I² = 14%
Test for overall effect: Z = 1.59 (P = 0.11)
Mean
-5.5
-2.6
-6.63
SD
4.5
4.5
2.55
Total
41
15
18
74
Mean
-5.8
-1.2
-4.99
SD
4.5
2.5
2
Total
35
14
16
65
Weight
31.1%
19.7%
49.3%
100.0%
IV, Random, 95% CI
0.30 [-1.73, 2.33]
-1.40 [-4.03, 1.23]
-1.64 [-3.17, -0.11]
-0.99 [-2.21, 0.23]
Yoghurt Control Mean Difference
? ? ? ? ? –
+ + + + + +
+ + + + + +
Risk of Bias
A B C D E F
Mean Difference
IV, Random, 95% CI
-4 -2 0 2 4
Favours yoghurt Favours control
Study or Subgroup
Thomas
Zemel
Total (95% CI)
Heterogeneity: Tau² = 0.00; Chi² = 0.02, df = 1 (P = 0.88); I² = 0%
Test for overall effect: Z = 2.34 (P = 0.02)
Mean
-2.6
-6.63
SD
4.5
2.55
Total
15
18
33
Mean
-1.2
-4.99
SD
2.5
2
Total
14
16
30
Weight
25.4%
74.6%
100.0%
IV, Random, 95% CI
-1.40 [-4.03, 1.23]
-1.64 [-3.17, -0.11]
-1.58 [-2.90, -0.26]
Yoghurt Control Mean Difference
+ + + + + +
+ + + + + +
Risk of Bias
A B C D E F
Mean Difference
IV, Random, 95% CI
-4 -2 0 2 4
Favours yoghurt Favours control
Study or Subgroup
Shilsky
Zemel
Total (95% CI)
Heterogeneity: Tau² = 5.87; Chi² = 6.81, df = 1 (P = 0.009); I² = 85%
Test for overall effect: Z = 0.80 (P = 0.43)
Mean
-4.9
-3.99
SD
3.6
2.04
Total
41
18
59
Mean
-5.2
-0.58
SD
3.7
4.16
Total
35
16
51
Weight
52.2%
47.8%
100.0%
IV, Random, 95% CI
0.30 [-1.35, 1.95]
-3.41 [-5.66, -1.16]
-1.47 [-5.11, 2.16]
Yoghurt Control Mean Difference
? ? ? ? ? –
+ + + + + +
Risk of Bias
A B C D E F
Mean Difference
IV, Random, 95% CI
-4 -2 0 2 4
Favours yoghurt Favours control
Study or Subgroup
Shilsky
Zemel
Total (95% CI)
Heterogeneity: Tau² = 0.81; Chi² = 2.06, df = 1 (P = 0.15); I² = 51%
Test for overall effect: Z = 0.90 (P = 0.37)
Mean
-4.6
-4.43
SD
3.8
1.99
Total
41
18
59
Mean
-4.7
-2.75
SD
3.9
2.92
Total
35
16
51
Weight
49.5%
50.5%
100.0%
IV, Random, 95% CI
0.10 [-1.64, 1.84]
-1.68 [-3.38, 0.02]
-0.80 [-2.54, 0.94]
Yoghurt Control Mean Difference
? ? ? ? ? –
+ + + + + +
Risk of Bias
A B C D E F
Mean Difference
IV, Random, 95% CI
-4 -2 0 2 4
Favours yoghurt Favours control
Figure 2. Forest plot of comparison: yoghurt vs control as part of an energy-restricted diet in mostly overweight/obese participants. Risk of
bias: (A) random sequence generation; (B) allocation concealment; (C) blinding of participants and personnel; (D) incomplete outcome data;
(E) selective reporting; (F) other bias. (a) Outcome: change in body weight. (i) All three RCTs. (ii) Sensitivity analysis excluding RCT with a high
risk of bias. (b) Outcome: change in WC. (c) Outcome: change in body fat.
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Two cohort studies provided evidence for a negative associa-
tion between yoghurt consumption and WC in overweight people
over a follow-up period of 6 or 12.9 years, but did not provide a
direct comparison between yoghurt and a control.38,39 A positive
association between low-fat yoghurt and WC was reported in
another small cohort study, but there was a lack of correction for
other diet factors in the analysis.35 A signiﬁcant negative
association between yoghurt consumption and WC for both sexes
together was reported by three cross-sectional studies.40,41,45 The
cohort and most cross-sectional studies adjusted for confounding
factors such as age, baseline weight, diet and lifestyle factors.
Yoghurt consumption and body fat
One RCT (low risk of bias) and one cross-sectional study (moderate
risk of bias) indicated that consumers of yoghurt had signiﬁcantly
lower body fat compared with a control group (Table 2).
Conversely, three RCTs (one low, two high risk of bias) did not
ﬁnd a signiﬁcant difference.
Evidence from one low risk of bias RCT30 indicated that yoghurt
consumption can signiﬁcantly decrease the amount of body fat
and trunk fat of overweight/obese people compared with no
yoghurt consumption over 12 weeks when on an energy-
restricted diet.
One low27 and two high risk of bias26,29 RCTs reported no
signiﬁcant difference between yoghurt and control groups in
primarily overweight/obese yoghurt consumers, on a calorie-
deﬁcit diet and/or resistance training. Comparator groups were an
isotonic placebo beverage,27 no added yoghurt and standard
protein26 and carbohydrate only or carbohydrate and protein.29
The forest plot in Figure 2c compares the change in body fat
between participants consuming yoghurt compared with a
control from the studies that were similar enough to be
combined.26,30 All participants were on an energy-restricted diet
and were either overweight or obese at baseline. The summary
effect size showed no beneﬁt for yoghurt over the comparator in
terms of change in body fat: − 0.80 (95% CI: − 2.54, 0.94). Shilsky
et al.26 had a high risk of bias, thus the summary effect must be
viewed with caution. The summary effect size was not signiﬁcant
for the ﬁxed-effect model (Z=− 1.31; P= 0.19). Heterogeneity was
on the borderline of moderate and substantial (I2 = 51%) for both
the ﬁxed-effect and random-effects models, suggesting caution
should be exercised in the interpretation of the summary effect
size. This heterogeneity may be because of differences in
participant numbers, baseline characteristics and comparators.
The cross-sectional study by Joshi et al.43 (moderate risk of bias)
reported that female yoghurt consumers had signiﬁcantly less
body fat compared with non-yoghurt consumers; another cross-
sectional study reported signiﬁcant inverse associations between
yoghurt consumption and body fat and abdominal fat,45 whereas
a cohort study did not ﬁnd an association.35
Yoghurt consumption and lean body mass
One RCT30 (low risk of bias) reported that consumers of yoghurt
had lost signiﬁcantly less lean body mass compared with a control
group (Table 2). Conversely, two RCTs (one low,27 one high risk of
bias29) did not ﬁnd a signiﬁcant difference.
Evidence from one RCT,30 which was at low risk of bias shows
that when on a calorie-restricted diet, overweight/obese con-
sumers of yoghurt lost signiﬁcantly less lean body mass compared
with the control participants (overweight/obese non-consumers of
yoghurt) over 12 weeks. In contrast, there was no difference in the
percent lean body mass increase observed in both yoghurt and
control groups in the two RCTs that incorporated resistance
training into the trial.27,29 One trial in overweight/obese people,
used an isotonic placebo beverage as the comparator, reported
after 8 weeks and was at low risk of bias.27 The other study did not
report the body weight of the study population, provided
carbohydrate only or carbohydrate and protein as the comparator,
reported at 16 weeks and was at high risk of bias.29 The studies
could not be pooled in a meta-analysis because of differences in
outcome reporting and involvement in diets.
Yoghurt consumption and risk/proportion of overweight/obesity
One large prospective cohort study (low risk of bias) provided
comparative evidence that high consumers of yoghurt who were
not overweight at baseline had a signiﬁcantly lower risk of
overweight/obesity compared with low consumers (Table 2).34
A retrospective cohort study found a nonsigniﬁcant reduction in
the odds of overweight people becoming obese with increasing
yoghurt consumption.37
Evidence from two comparative cross-sectional studies (one at
low risk of bias and one at moderate risk of bias) showed that
yoghurt consumption was associated with lower risk or prevalence
of overweight/obesity compared with low or no yoghurt
consumption in females.40,42 One cross-sectional study had
conﬂicting results depending on how yoghurt intake was
measured,44 and another showed a negative association between
yoghurt consumption and both obesity and central obesity.41
Most of the cohort and cross-sectional studies adjusted for
confounding factors such as age, baseline weight, diet and
lifestyle factors.
DISCUSSION
The aim of this review was to examine the available evidence on
the effects of conventional yoghurt consumption on weight-
related outcomes. We found evidence from studies comparing
yoghurt to other interventions supporting an association between
yoghurt consumption and lower BMI, lower body weight/weight
gain, smaller WC and lower body fat in normal-weight, overweight
and obese people and/or the general population. We did not ﬁnd
evidence of causality.
Only one of ﬁve RCTs reported signiﬁcant favourable weight-
related outcomes for yoghurt compared with the control group,
although pooling of data from other RCTs supported the effect for
body weight. Control group data from RCTs indicated that energy-
restricted diets with/without resistance training may produce
more favourable weight-related outcomes (body weight, WC,
body fat and lean body mass) for overweight/obese people, rather
than the yoghurt supplementation itself. We recognise that the
RCTs were small sized, and generally focused on overweight/
obese people and energy-restricted diets with/without exercise,
limiting the generalisability of the outcomes from these studies.
Two RCTs28,29 reported an increase in body weight with yoghurt
consumption, with a similar body weight increase also being
reported in some, but not all comparator groups. One of these
trials28 did not have weight loss as an outcome and gave a
supplement of 1 L of several dairy products in addition to the
participants’ usual dietary intakes. This extra dairy intake may be
an explanation for the observed weight gain. In the second RCT,29
the primary outcome was also not weight loss and participants
were exercising. They had a 1.1 kg rise in body weight, but a rise in
fat-free mass of 2 kg and a loss in fat mass of 0.9 kg, suggesting
that there is a shift from fat mass to lean mass.47,48
High yoghurt consumption was associated with a lower risk of
overweight/obesity compared with low yoghurt consumption.
This trend varied with race in some studies: it was not seen in
Asian people when using 24-h recall data (participants in one
cross-sectional study44), or in non-Hispanic Black populations
(subgroup analysis in one study41). Again, because of the potential
for residual confounding within these observational studies, this
ﬁnding should be interpreted with caution.
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Limitations of the evidence
We found poor reporting and an absence of detail in many reports
and when contacting authors directly, which limited our ability to
compare studies and also our ability to assess the methodological
quality of studies. Only one study reported the bacterial strain of
yoghurt. Particularly in cohort or cross-sectional studies, which
often used questionnaires or food diaries to ascertain yoghurt
consumption, different deﬁnitions and interpretations of ‘yoghurt’
may have introduced some noise into the data, for example,
probiotic yoghurt may have been included. None of the studies
was prospectively registered in ClinicalTrials.gov or the registers
accessed via the International Clinical Trials Registry Platform. This
might be seen as an indicator of risk of bias, but we note that
currently few systematic reviews could be completed based on
registered trials alone.49
Yoghurt consumption is highly likely to be linked to healthy
eating and lifestyle attributes, which are, in turn, likely to be linked
to positive weight-related outcomes (i.e. lower BMI), creating a
systematic bias. Very often, several of these attributes occur
together in individuals, inﬂating the confounding effect. Con-
founders important for this topic include, but are not limited to:
socioeconomic status; energy intake; diet quality; physical activity
levels; body weight at baseline; gender and race. Some, but not all
of the potential confounders were added as covariates in analyses
by the included studies, indicating that residual confounding is
likely to remain. For example, socioeconomic status is likely to be a
major confounder, but it was only reported by half of the cohort
and less than half of the cross- sectional studies.
The studies retrieved for this review were heterogeneous in
aspects of their study design, populations, treatment groups and
outcomes, an expected outcome of including different study types
in this review. Because of the differences between studies, there
were only a limited number of studies that were suitable for
combination into a meta-analysis. Residual variation between the
studies that were combined led to heterogeneity within the meta-
analysis (as seen in the high I2 statistics in summary effect sizes for
WC and body fat, although not for body weight), and, in turn, a
low conﬁdence in summary estimates.
Although we investigated the possibility of combining data
from single arms from studies of different designs that were
conducted in similar ways, in a meta-analysis, we found no
instances where study arms could be combined, partly because of
the lack of comparable study types: there were only two cross-
over trials.
Because of the high heterogeneity between studies, combining
our narrative summaries with an examination of individual study
results will give a more complete and reliable reﬂection of the
evidence base.
Sometimes, studies did not report comparative data (i.e.
between yoghurt and a comparator, or yoghurt and low/no
yoghurt groups). This information is key in separating the effects
of treatment group and the lack of this information limited our
ability to draw robust conclusions from the studies. Because not all
studies reported comparative data, we also report non-
comparative data. Although this type of data represents a lower
strength of evidence, it provides additional information to support
conclusions drawn from comparative data.
Limitations of this review
In any review of evidence, there is a potential for publication bias,
where the body of published evidence is not representative of the
studies that have been conducted in a particular topic area. There
were not enough comparable studies (with similar outcome
measures and timescales) to reliably assess the potential for
publication bias. Until more studies in this topic are available, we
must assume that there is a potential for this review to be
inﬂuenced by publication bias to an unknown extent.
Recommendations for future research
We recommend that future experimental studies addressing this
question use standard, non-probiotic yoghurt cultures, deﬁne the
type of yoghurt and the cultures included and use amounts of
yoghurt similar to those consumed in the general population.
Predeﬁned or post hoc analyses of subgroups (e.g. race, gender,
socioeconomic class) could be undertaken separately. In particu-
lar, because of the potential for gender-related bias in yoghurt
consumption (identiﬁed by studies in this review), both sexes
should be included, and either analysed separately or gender
added as a covariate in analysis.
In future studies, the comparator should be no yoghurt
consumption with yoghurt replaced by an isocaloric replacement
food, to separate the effect of yoghurt. In cases where using this
comparator may compromise blinding, an appropriate placebo
product, such as a gelatin-based dessert, could be used as a
comparator. Another study design could use two distinct
interventions, with each intervention acting as the other’s control.
Future studies should be powered appropriately to maximise
the likelihood of detecting a causal effect. Cohort and cross-
sectional studies can enable an assessment of the outcome effect
in the ‘real-world’ context, including and controlling for con-
founders in analyses. Blinded or placebo-controlled RCTs in a
community-based setting, controlling for other diet and lifestyle
factors (e.g. a normal, stable diet and exercise regime) may be able
to separate the treatment effect of yoghurt, although the controls
may not be representative of yoghurt consumers in the general
population. Whatever the study type, full measurement, inclusion
and reporting the impact of potential confounders in analyses are
imperative in all future studies, because of their high potential
importance in this area.
We recommend that studies include and report comparative
analyses between intervention groups, maximising the availability
of combinable data for future meta-analysis.
Future studies in this topic should measure the following
outcomes: BMI, body weight, % body fat, % lean body mass and
WC, and measurements should be undertaken by health
professionals, rather than self-reported, to minimise error. We
recommend that, to show meaningful (long term and stable)
weight-related outcomes, the minimum duration of yoghurt
intervention should be 12 months. However, shorter term studies,
such as 3 months, can be a useful proof of principle.
We recommend that any future studies be registered (e.g. in
ClinicalTrials.gov) and carefully planned to minimise their risk of
bias, so that they may be suitable for combination in meta-
analysis. Examples of studies with a low risk of bias are the RCTs by
Thomas et al.27 and Zemel et al.,30 the prospective cohort study by
Martinez-Gonzalez et al.34 and most of the cross-sectional studies.
We recommend that published study reports should provide
details that would enable reviewers to extract data, assess the
methodological quality of the study and maximise the potential
for inclusion in meta-analyses. The speciﬁc information required
will vary between study types, but the following areas are where
we have experienced a lack of information:
● Basic study information such as country of study, study dates
and whether the study is prospective or retrospective.
● Inclusion and exclusion criteria.
● Baseline population characteristics (by intervention group),
including age, sex, baseline weight-related outcomes measures,
ethnicity, prognostic and confounding factors (e.g. socio-
economic status, diet and exercise levels).
● Intervention and comparator details including dosing regimen
and the strains and type of yoghurt used.
● Full details of analysis methods and justiﬁcation for sample
sizes used.
● Follow-up times.
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● Numbers of non-respondents or dropouts by intervention
group, with reasons for dropout.
● Outcome data as means and s.d.s or odds ratios.
● Comparative data from analyses, including P-values.
We also recommend that future studies provide full details of
the adjustment for confounders in the methods section of their
reports. This should include detailing the rationale behind
including the potential confounders, how the data was collected,
how it was inputted as a covariate in the analysis and whether the
analysis showed any association between yoghurt consumption
and the confounder. The current literature is dominated by studies
from the United States of America, and we suggest that more
studies be conducted in European countries, where yoghurt has
been more traditionally consumed.
CONCLUSIONS
There is evidence to suggest that yoghurt consumption is associated
with lower BMI, lower body weight/weight gain, smaller WC and
lower body fat in a mix of normal-weight, overweight and obese
people and/or the general population. We acknowledge the
limitations that stem from heterogeneous study designs, small sizes
of RCTs, the uncertainties around confounding and the inclusion of
non-comparative data and unclear/moderate/high risk of bias
studies. The data therefore suggests a role for yoghurt in weight
management, but cannot determine a cause–effect relationship.
We conclude that the evidence in the literature from cross-
sectional and cohort studies is sufﬁciently positive that additional
studies of this type will be superﬂuous. Well-designed, RCTs with
adequate numbers for sufﬁcient power are needed to get a better
understanding of the possible mechanisms of action and the
plausible cause–effect relationships. Consumption of yoghurt will
not be a panacea for overweight/obesity, but the simple addition
of yoghurt to the daily diet may facilitate signiﬁcant loss of body
fat. This relatively achievable and low-cost dietary change could
thereby help in minimising the impact of obesity and improve
public health.
The potential of yoghurt for improving body weight/composi-
tion calls for increasing funding for research in this area.
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